Aion Therapeutic Inc. (AION.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.19 Million CAD | N/A |
| 2022 | -1.08 Million CAD | -45260.48% |
| 2021 | -2390.86 CAD | 8.12% |
| 2020 | -2602.23 CAD | 99.74% |
| 2019 | -996.64 Thousand CAD | 41.4% |
| 2018 | -1.7 Million CAD | -719.94% |
| 2017 | -207.42 Thousand CAD | -65.17% |
| 2016 | -125.58 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -239.23 Thousand CAD | 9.96% |
| 2023 Q1 | -165.3 Thousand CAD | 40.63% |
| 2023 Q2 | -265.69 Thousand CAD | -60.73% |
| 2022 Q1 | -331.75 Thousand CAD | 76.5% |
| 2022 Q3 | -246.95 Thousand CAD | -8.61% |
| 2022 Q2 | -227.37 Thousand CAD | 31.46% |
| 2022 Q4 | -278.41 Thousand CAD | -12.74% |
| 2022 FY | -1.08 Million CAD | -45260.48% |
| 2021 FY | -2390.86 CAD | 8.12% |
| 2021 Q4 | -1.41 Million CAD | -125.76% |
| 2021 Q3 | -625.41 Thousand CAD | 20.3% |
| 2021 Q2 | -784.75 Thousand CAD | -70.12% |
| 2021 Q1 | -461.3 Thousand CAD | 57.69% |
| 2020 Q1 | -463.7 Thousand CAD | -106.3% |
| 2020 Q3 | -528.61 Thousand CAD | 24.2% |
| 2020 Q2 | -697.35 Thousand CAD | -50.39% |
| 2020 FY | -2602.23 CAD | 99.74% |
| 2020 Q4 | -1.09 Million CAD | -106.27% |
| 2019 Q1 | -356.19 Thousand CAD | 25.1% |
| 2019 Q2 | -201.35 Thousand CAD | 43.47% |
| 2019 Q3 | -200.31 Thousand CAD | 0.52% |
| 2019 Q4 | -224.77 Thousand CAD | -12.21% |
| 2019 FY | -996.64 Thousand CAD | 41.4% |
| 2018 Q2 | -673.39 Thousand CAD | -226.34% |
| 2018 FY | -1.7 Million CAD | -719.94% |
| 2018 Q4 | -475.55 Thousand CAD | -37.66% |
| 2018 Q3 | -345.46 Thousand CAD | 48.7% |
| 2018 Q1 | -206.34 Thousand CAD | 87.66% |
| 2017 Q4 | -1.67 Million CAD | -742.1% |
| 2017 FY | -207.42 Thousand CAD | -65.17% |
| 2017 Q2 | -655.66 Thousand CAD | 0.0% |
| 2017 Q3 | -198.58 Thousand CAD | 69.71% |
| 2016 FY | -125.58 Thousand CAD | 0.0% |
| 2015 Q3 | -8900.00 CAD | 0.0% |
| 2015 Q1 | -3048.00 CAD | 0.0% |
| 2014 Q3 | -10.8 Thousand CAD | 0.0% |
| 2014 Q1 | -8716.00 CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ayurcann Holdings Corp. | -3.25 Million CAD | 63.365% |
| Blueberries Medical Corp. | -1.22 Million CAD | 2.904% |
| The BC Bud Corporation | -1.22 Million CAD | 2.659% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 81.296% |
| CordovaCann Corp. | -2.51 Million CAD | 52.6% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -35.251% |
| Captor Capital Corp. | 655.2 Thousand CAD | 281.766% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -19.519% |
| 1CM Inc. | 300.79 Thousand CAD | 495.939% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -115.866% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 69.298% |
| IM Cannabis Corp. | -12.17 Million CAD | 90.218% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 64.549% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -203.646% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 62.619% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 319.623% |
| Ovation Science Inc. | -764 Thousand CAD | -55.882% |
| Pharmadrug Inc. | -1.33 Million CAD | 10.791% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -4.289% |
| RAMM Pharma Corp. | -7.08 Million CAD | 83.193% |
| RIV Capital Inc. | 1.78 Million CAD | 166.898% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 63.757% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 86.419% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 80.106% |
| 1933 Industries Inc. | -9.34 Million CAD | 87.262% |
| Red Light Holland Corp. | -6.44 Million CAD | 81.525% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -51.752% |
| Xebra Brands Ltd. | -1.55 Million CAD | 23.389% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 33.606% |